143 related articles for article (PubMed ID: 23587114)
21. Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment.
Arenas M; Arguís M; Díez-Presa L; Henríquez I; Murcia-Mejía M; Gascón M; Gómez D; Lafuerza A; Mur E; Azón A; Rovirosa À; Sabater S
Brachytherapy; 2015; 14(6):859-65. PubMed ID: 26489922
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcome and toxicity in a Phase I/II trial using high-dose-rate multicatheter interstitial brachytherapy for T1/T2 breast cancer.
Kaufman SA; DiPetrillo TA; Price LL; Midle JB; Wazer DE
Brachytherapy; 2007; 6(4):286-92. PubMed ID: 17991625
[TBL] [Abstract][Full Text] [Related]
24. Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer-An analysis of 273 lesions.
Olek D; El-Ghamry MN; Deb N; Thawani N; Shaver C; Mutyala S
Brachytherapy; 2018; 17(3):601-608. PubMed ID: 29398593
[TBL] [Abstract][Full Text] [Related]
25. Review: the reemergence of brachytherapy as treatment for non-melanoma skin cancer.
Ota K; Adar T; Dover L; Khachemoune A
J Dermatolog Treat; 2018 Mar; 29(2):170-175. PubMed ID: 28604229
[TBL] [Abstract][Full Text] [Related]
26. Hypofractionated radiation therapy for basal and squamous cell skin cancer: A meta-analysis.
Zaorsky NG; Lee CT; Zhang E; Keith SW; Galloway TJ
Radiother Oncol; 2017 Oct; 125(1):13-20. PubMed ID: 28843727
[TBL] [Abstract][Full Text] [Related]
27. Accelerated partial breast irradiation: an analysis of variables associated with late toxicity and long-term cosmetic outcome after high-dose-rate interstitial brachytherapy.
Wazer DE; Kaufman S; Cuttino L; DiPetrillo T; Arthur DW
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):489-95. PubMed ID: 16246495
[TBL] [Abstract][Full Text] [Related]
28. The American Brachytherapy society consensus statement for skin brachytherapy.
Shah C; Ouhib Z; Kamrava M; Koyfman SA; Campbell SR; Bhatnagar A; Canavan J; Husain Z; Barker CA; Cohen GN; Strasswimmer J; Joshi N
Brachytherapy; 2020; 19(4):415-426. PubMed ID: 32409128
[TBL] [Abstract][Full Text] [Related]
29. Penile brachytherapy: results for 49 patients.
Crook JM; Jezioranski J; Grimard L; Esche B; Pond G
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):460-7. PubMed ID: 15890588
[TBL] [Abstract][Full Text] [Related]
30. Two fractions of high-dose-rate brachytherapy in the management of cervix cancer: clinical experience with and without chemotherapy.
Sood BM; Gorla G; Gupta S; Garg M; Deore S; Runowicz CD; Fields AL; Goldberg GL; Anderson PS; Vikram B
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):702-6. PubMed ID: 12062615
[TBL] [Abstract][Full Text] [Related]
31. Electronic brachytherapy and superficial radiation therapy: will you be adding it to your practice?
David CV
Cutis; 2013 Nov; 92(5):E16-8. PubMed ID: 24343219
[No Abstract] [Full Text] [Related]
32. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer.
Lancellotta V; Kovács G; Tagliaferri L; Perrucci E; Rembielak A; Stingeni L; Tramontana M; Hansel K; Colloca G; Saldi S; Valentini V; Aristei C
J Geriatr Oncol; 2019 May; 10(3):514-517. PubMed ID: 30314955
[TBL] [Abstract][Full Text] [Related]
33. A novel conformal superficial high-dose-rate brachytherapy device for the treatment of nonmelanoma skin cancer and keloids.
Ferreira C; Johnson D; Rasmussen K; Leinweber C; Ahmad S; Jung JW
Brachytherapy; 2017; 16(1):215-222. PubMed ID: 27720205
[TBL] [Abstract][Full Text] [Related]
34. High dose rate brachytherapy in early stage squamous-cell carcinoma of the lip.
Mut A; Guinot JL; Arribas L; Díez-Presa L; Tortajada MI; Santos MÁ; Samper J; Santamaría P; Vendrell JB
Acta Otorrinolaringol Esp; 2016; 67(5):282-7. PubMed ID: 27063585
[TBL] [Abstract][Full Text] [Related]
35. Complete response of endemic Kaposi sarcoma lesions with high-dose-rate brachytherapy: treatment method, results, and toxicity using skin surface applicators.
Kasper ME; Richter S; Warren N; Benda R; Shang C; Ouhib Z
Brachytherapy; 2013; 12(5):495-9. PubMed ID: 23466358
[TBL] [Abstract][Full Text] [Related]
36. Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year.
Bhatnagar A
Brachytherapy; 2013; 12(2):134-40. PubMed ID: 23312675
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of effective treatment depth in skin cancer treatments with electronic brachytherapy.
Lloyd SAM; Rahn DA; Hoisak JDP; Dragojević I
Brachytherapy; 2018; 17(6):990-994. PubMed ID: 30217433
[TBL] [Abstract][Full Text] [Related]
38. A case-control study of patients with squamous cell carcinoma of the oral cavity and oropharynx treated with pulsed-dose-rate brachytherapy.
Haddad A; Peiffert D; Lapeyre M; Harter V; Buchheit I; Graff P
Brachytherapy; 2014; 13(6):597-602. PubMed ID: 24913434
[TBL] [Abstract][Full Text] [Related]
39. High-dose-rate brachytherapy using molds for lip and oral cavity tumors.
Unetsubo T; Matsuzaki H; Takemoto M; Katsui K; Hara M; Katayama N; Waki T; Kanazawa S; Asaumi J
Radiat Oncol; 2015 Apr; 10():81. PubMed ID: 25888772
[TBL] [Abstract][Full Text] [Related]
40. Evaluating reimbursement of skin radiation therapy: Technique and fractionation.
Shah C; Kamrava M; Thaker NG
Brachytherapy; 2020; 19(5):700-704. PubMed ID: 32682776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
